Dermorphin, a peptide (short protein-like chain) from South American frog skin, acts on the same pain-relief docking site as morphine and was studied for pain after surgery. In one hospital study, a single injection into the spinal fluid relieved pain longer than comparison drugs; nothing has replicated it. Severe reported harms come from ritual use of the raw frog secretion. No product reached the market; nothing can be sourced lawfully. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum sodium | 135–145 mmol/L (standard reference range) | Safety check: the documented life-threatening harm is acute low sodium |
| Serum osmolality (paired with urine osmolality and urine sodium) | 275–295 mOsm/kg (standard reference range) | Safety check: separates water loading from inappropriate antidiuretic hormone release |
| Creatine kinase | 20–200 U/L (standard reference range; laboratory- and sex-dependent) | Safety check: muscle breakdown after seizures or prolonged vomiting |
| Alanine aminotransferase (paired with bilirubin and gamma-glutamyl transferase) | 7–55 U/L (standard reference range; laboratory- and sex-dependent) | Safety check: liver injury, which has followed ritual exposure |
| Serum cortisol | 5–25 µg/dL at 08:00 (standard reference range) | Expected to change: human infusion lowered cortisol |
| Serum prolactin | 4–15 ng/mL (men), 4–23 ng/mL (non-pregnant women) (standard reference range) | Expected to change: human infusion raised prolactin; absent response flags pituitary disease |
Cadence: Baseline before any supervised exposure; sodium and osmolality within 2–6 hours and again at 24 hours whenever vomiting, headache, confusion or seizure occurs; creatine kinase and alanine aminotransferase at 24 hours after a seizure or prolonged vomiting; hormones repeated only if a baseline value was abnormal; nothing to track beyond 48 hours.